Fig 1.
Flow diagram of trial participation.
Table 1.
Baseline characteristics of study participants.
Fig 2.
Changes in NPZ-7 and in information processing speed and executive functioning domains.
(a) Mean change in NPZ-7. (b) Mean change in information processing speed. (c) Mean change in executive functioning. Values are expressed as z-score means, bars as standard errors. P values and d sizes are provided for rivastigmine vs control group comparisons. Abbreviations: CG, control group; EF, executive functioning; IPS, information processing speed; LG, lithium group; RG, rivastigmine group.
Table 2.
Change in cognitive measures at week 48.
Table 3.
Change in daily living, quality of life, and emotional variables.